Trigeminal Neuralgia: Modern Methods of Pain Treatment

What is Trigeminal Neuralgia?

Trigeminal neuralgia, also known as tic douloureux, is a chronic pain disorder affecting the trigeminal nerve, which is responsible for carrying sensations from your face to your brain. This condition is characterized by sudden, severe, stabbing, or shooting pains that are often described as an electric shock. The pain usually occurs on one side of the face, affecting the jaw, cheek, or forehead, and can be triggered by everyday activities such as chewing, speaking, touching the face, or even a light breeze. Although the exact causes may vary, neuralgia is frequently associated with compression of the trigeminal nerve by a blood vessel. This disease significantly reduces the quality of life of patients, requiring a comprehensive and often individualized approach to treatment.

Modern Approaches to Pharmacotherapy

First-line therapy for trigeminal neuralgia typically involves medication management. Anticonvulsant drugs are the cornerstone of the pharmacological approach because they help stabilize nerve membranes and reduce the abnormal electrical activity that causes pain. However, when standard medications prove ineffective or cause undesirable side effects, other options are considered. For example, in studies of migraine, which is also a chronic pain syndrome, the efficacy of nerve blocks using amitriptyline—a tricyclic antidepressant often used to treat chronic pain—was compared [4]. Although amitriptyline is not a primary drug for trigeminal neuralgia, this example demonstrates that various drug groups can be used to treat chronic pain syndromes, including those that affect neurotransmitters or modulate pain pathways. The choice of drug therapy should always be individualized and conducted under medical supervision.

Invasive Methods: Nerve Blocks and Radiofrequency Ablation

When medical treatment does not provide sufficient relief, invasive procedures may be considered. One such method is nerve blocks, which involve the injection of anesthetics or other substances directly into the nerve area to block pain signals. Studies show high efficacy of greater occipital nerve (GON) and supraorbital nerve (SON) blocks in treating migraines, indicating the potential of similar approaches for other types of facial and head pain, including trigeminal neuralgia [2, 4].

• Nerve Blocks: Injection of a local anesthetic (e.g., 0.25% bupivacaine) under ultrasound guidance allows for precise targeting of the affected nerve, providing temporary pain relief. Repeated blocks can be effective for patients who regularly visit the clinic [2].
• Pulsed Radiofrequency Ablation (PRF): This method uses radiofrequency waves to generate controlled heat that modulates nerve fibers, reducing the transmission of pain signals. Studies compare the efficacy of greater occipital nerve pulsed radiofrequency (GONPRF) with repeated nerve blocks, showing that both methods can be effective in managing chronic pain [2]. The use of ultrasound guidance significantly increases the precision and safety of the procedure.

These methods offer longer-term relief compared to conventional injections and can be particularly useful for patients who do not respond to conservative therapy.

Botulinum Therapy in Combating Chronic Pain

Botulinum toxin type A (onabotulinumtoxinA) injections have proven to be an effective tool for the prevention of chronic migraine and can be applied in the treatment of other types of chronic neuropathic pain, including trigeminal neuralgia. Standard injection protocols, such as PREEMPT (Phase III Research Evaluating Migraine Prophylaxis Therapy), use fixed injection points. However, there are also anatomically oriented strategies aimed at specific peripheral nerve trigger zones that may be more effective [7]. Botulinum toxin works by blocking the release of neurotransmitters involved in pain transmission, leading to a decrease in the frequency and intensity of pain attacks. This method can be especially valuable for patients in whom other treatments have proven ineffective or are contraindicated.

Promising Directions: Neuromodulation and Growth Factors

Scientific research continues to open new horizons in the treatment of chronic pain. Neuromodulation, such as transcutaneous vagus nerve stimulation (t-VNS), demonstrates potential in modulating the autonomic nervous system to improve cardiac function in heart failure [1]. Although this study does not directly address trigeminal neuralgia, it highlights the growing interest in non-invasive nerve stimulation methods to impact chronic conditions. Similar approaches can be adapted to modulate pain pathways in neuralgia.

Another promising direction is the use of growth factors. For example, nerve growth factor (NGF) plays a key role in the growth, development, and differentiation of central and peripheral neurons [3]. In ophthalmology, biological products targeting growth factors are already being used to treat conditions such as neurotrophic keratitis and corneal injuries [3]. Theoretically, NGF or other growth factors could promote the regeneration of damaged nerves or modulate their function, potentially becoming a breakthrough treatment for trigeminal neuralgia in the future, especially in cases associated with nerve damage.

Individualized Approach to Therapy

The treatment of trigeminal neuralgia requires a comprehensive and strictly individualized approach. The effectiveness of various methods can vary significantly from patient to patient. Close collaboration between the patient and the physician is important to select the most appropriate strategy, which may include a combination of drug therapy, invasive procedures, and possibly participation in clinical trials of new methods. The goal of treatment is not only to reduce pain but also to improve the patient's overall quality of life while minimizing side effects and risks.

Sources

• [1] The efficacy of transcutaneous vagus nerve stimulation in heart failure management - a systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/40615792/
• [2] Comparison of the Efficacy of Ultrasound-Guided Repeated Greater Occipital Nerve Blocks and Greater Occipital Nerve Pulsed Radiofrequency in Migraine Treatment. https://pubmed.ncbi.nlm.nih.gov/40773641/
• [3] Progress on the application of growth factor-related drugs in ophthalmology. https://pubmed.ncbi.nlm.nih.gov/36581569/
• [4] Comparison of greater occipital and supraorbital nerve block with amitriptyline use in migraine treatment. https://pubmed.ncbi.nlm.nih.gov/42459176/
• [7] Comparing Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) and Targeted Approaches for OnabotulinumtoxinA in Chronic Migraine Treatment. https://pubmed.ncbi.nlm.nih.gov/42221291/

The information provided in this article is for informational purposes only and should not be used for self-diagnosis or self-treatment. Always consult a qualified medical professional for an accurate diagnosis and an individualized treatment plan.